Addex Therapeutics (ADXN) Short-term Investments (2018 - 2026)

Addex Therapeutics has reported Short-term Investments for 9 years, with the latest figure at $2997.1 in Q1 2026.

• Quarterly Short-term Investments fell 60.54% year-over-year to $2997.1 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2997.1 (down 60.54% YoY) and the FY2025 annual result came in at $6187.4, down 16.2% from the prior year.
• Short-term Investments retreated to $2997.1 in Q1 2026 per ADXN's latest filing, from $6418.5 in the prior quarter.
• Over five years, Short-term Investments peaked at $18622.3 in Q2 2023 and troughed at $482.3 in Q3 2023.
• A 5-year average of $5704.2 and a median of $4456.6 in 2023 frame the typical range for Short-term Investments.
• The sharpest annual moves came in 2022 and 2024: Short-term Investments plunged 91.2% in 2022, then surged 1083.65% in 2024.
• Over 5 years, Short-term Investments stood at $3285.3 in 2022, then sank by 70.9% to $956.0 in 2023, then surged by 675.66% to $7415.3 in 2024, then fell by 13.44% to $6418.5 in 2025, then sank by 53.3% to $2997.1 in 2026.
• According to Business Quant data, Short-term Investments over the past three periods registered $2997.1, $6418.5, and $8575.8 for Q1 2026, Q4 2025, and Q3 2025 respectively.